Clinical Trial Update: A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a vaccine booster GEO-CM04S1 to prevent COVID-19 in patients with chronic lymphocytic leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• GEO-CM04S1

Snippet

Sponsor: City of Hope Medical Center | Conditions: Chronic Lymphocytic Leukemia, COVID-19 Infection | Phase 2 | Status: RECRUITING